share_log

1.24亿美元!复星医药与和睦家“彻底分手”|速读公告

0.124 billion USD! FOSUN PHARMA and United Family Healthcare "completely part ways" | Quick announcement.

cls.cn ·  Mar 13 15:26

① FOSUN PHARMA's subsidiary plans to sell 6.6% of the equity of the target company for 0.124 billion USD; ② The connection between FOSUN PHARMA and United Family dates back to 2009; ③ After the completion of this Trade, FOSUN PHARMA will completely exit United Family.

According to the Financial Associated Press on March 13 (Reporter Lu Afeng), after more than ten years, FOSUN PHARMA completely exits United Family.

Today, FOSUN PHARMA (600196.SH) announced that its subsidiary FOSUN Industrial plans to transfer 9.4 million shares of common stock of the target company to Calcite Gem for a Cash consideration of 124.08 million USD, with a corresponding price per share of 13.2 USD.

According to the management's financial statements of the target company (consolidated and unaudited), as of December 31, 2024, the total Assets of the target company will be 8.936 billion yuan; in 2024, the target company will achieve revenue of 3.324 billion yuan.

According to the announcement, the main Assets of the target company consist of the 'United Family' hospitals and clinics operated and held through its holding subsidiary NFH (Newwind Medical). The Company Valuation corresponding to this Trade price (i.e., approximately 1.881 billion USD) corresponds to about 4.0 times the target company's 2023 revenue (P/S ratio) and 4.1 times the 2024 revenue (P/S ratio).

It is understood that Calcite Gem was established in July 2021 and is registered in the Cayman Islands. Calcite Gem is an investment holding company wholly owned by several Warburg Pincus investment funds. As of the announcement date, Calcite Gem Investments Ltd holds 100% equity of Calcite Gem.

United Family, the core asset, is one of the earliest private Medical institutions in China positioned as 'high-end comprehensive + international services', consistently ranking among the top three in foreign/ joint venture hospitals, and has long maintained the top position in the domestic market targeting foreigners and high-net-worth individuals.

The connection between FOSUN PHARMA and United Family can be traced back more than a decade. In November 2009, FOSUN PHARMA purchased stocks of United Family's parent company, Meizhong Huli, on the Nasdaq secondary market through FOSUN Industrial, reaching an ownership ratio of 11.18%. In 2014, FOSUN PHARMA formed a buyer group with private equity fund TPG and United Family founder Li Bijing's team to complete a privatization acquisition of Meizhong Huli. After this transaction was completed, FOSUN PHARMA held nearly 43% of the shares in Meizhong Huli through FOSUN Industrial.

In the following years, FOSUN PHARMA gradually sold its Assets in United Family Hospitals, and after this Trade is completed, it will no longer Hold equity in the symbol company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 1166

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.